help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 11, 2006, doi:10.1165/rcmb.2006-0012OC

Am. J. Respir. Cell Mol. Biol., Volume 35, Number 4, October 2006, 407-414

A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0012OCv1
35/4/407    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, K.-Y.
Right arrow Articles by Kuo, H.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, K.-Y.
Right arrow Articles by Kuo, H.-P.

Submitted on January 10, 2006
Revised on May 10, 2006

Neutrophil-derived Elastase Induces TGF-{beta}1 Secretion in Human Airway Smooth Muscle via NF-{kappa}B Pathway

Kang-Yun Lee1, Shu-Chuan Ho1, Horng-Chyuan Lin1, Shu-Min Lin1, Chien-Ying Liu1, Chien-Da Huang1, Chun-Hua Wang1, Kian Fan Chung2, and Han-Pin Kuo1*

1 Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan, 2 Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London, United Kingdom

* To whom correspondence should be addressed. E-mail: q8828{at}ms11.hinet.net.

Neutrophils are infiltrated in airways of more severe and chronic asthma with uncertain significance. Airway smooth muscle (ASM), apart from it contractile properties, is critically involved in the pathogenesis of asthma by producing inflammatory mediators. In the present study, we investigated the impact of neutrophil-derived elastase (NE) on ASM in terms of TGF-{beta}1 release and explored the underlying mechanisms. Primary ASM cells were serum starved for 24h before stimulation with NE (0.01-0.5 µg/ml). TGF-{beta}1 in supernatant was determined by ELISA and mRNA quantified by real-time RT-QPCR. NF-{kappa}B nuclear translocation and activation was examined by Western blotting and {kappa}B-2dEGFP reporter gene assay. Association of interleukin-1 receptor associated kinase (IRAK) with MyD88 was studied by co-immunoprecipitation and Toll like receptor 4 (TLR4) determined by FACS scan and Western blotting. We demonstrated that NE enhanced TGF-{beta}1 release in a time-dependent manner. This induction was inhibited by actinomycin D (5 mM), cycloheximide (5 mM) and NF-{kappa}B inhibitors, including pyrrolidine dithiocarbamate (PDTC, 1mM), aspirin (2.5 mM) and sodium salyicylate (2.5 mM). Stimulation with NE was rapidly followed by association of IRAK with MyD88, phosphorylation of I{kappa}B{alpha} and nuclear translocation of p65 with increased transactivation activity. We also found that TLR4 levels were reduced upon NE treatment. These data suggest that NE upregulates TGF-{beta}1 gene expression and release via My88/IRAK/NF-{kappa}B pathway, possible through activation of TLR4, and shed light on a potential role of neutrophils in the pathogenesis of asthma.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.
  ATS Best of the Web